Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Feb;22(2):130-135.
doi: 10.7499/j.issn.1008-8830.2020.02.009.

[Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China]

[Article in Chinese]
Yang Yang  1 , Rui Cheng, Qi Wu, Li-Xing Qiao, Zu-Ming Yang, Hong-Bing Gu, Shan-Yu Jiang, Song-Lin Liu, Shu-Hong Jiang
Affiliations
Multicenter Study

[Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China]

[Article in Chinese]
Yang Yang et al. Zhongguo Dang Dai Er Ke Za Zhi. 2020 Feb.

Abstract
in English, Chinese

Objective: To study the efficacy and safety of caffeine used in the early (≤72 hours after birth) and late (>72 hours after birth) stage in preterm infants with a gestational age of ≤31 weeks.

Methods: A retrospective analysis was performed for 640 preterm infants (with a gestational age of ≤31 weeks) who were admitted to the neonatal intensive care unit of eight hospitals in Jiangsu Province, China. Of the 640 preterm infants, 510 were given caffeine in the early stage (≤72 hours after birth; early use group) and 130 were given caffeine in the late stage (>72 hours after birth; late use group). The clinical data were compared between the two groups.

Results: There were no significant differences in birth weight, Apgar score, sex, gestational age, and age on admission between the two groups (P>0.05). Compared with the late use group, the early use group had a significantly younger age at the beginning and withdrawal of caffeine treatment (P<0.05) and a significantly shorter duration of caffeine treatment (P<0.05). There was no significant difference in respiratory support on admission between the two groups (P>0.05). Compared with the late use group, the early use group had significantly lower incidence rate of apnea (P<0.05) and significantly shorter oxygen supply time and length of hospital stay (P<0.05). There were no significant differences between the two groups in the incidence rates of neonatal intracranial hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity, and patent ductus arteriosus at discharge and NBNA score at the corrected gestational age of 40 weeks (P>0.05). However, significant differences were found in the incidence of bronchopulmonary dysplasia and the rate of home oxygen therapy, but there was no significant difference in the mortality rate between the two groups (P>0.05).

Conclusions: Early use of caffeine can shorten the duration of caffeine treatment, oxygen supply time, and length of hospital stay, with little adverse effect, in preterm infants with a gestational age of ≤31 weeks.

目的: 评估早产儿（胎龄≤31周）早期和晚期使用咖啡因的有效性和安全性。

方法: 从江苏省8家医院的新生儿重症监护室中回顾性选取640例胎龄≤31周的早产儿作为研究对象，其中早期应用咖啡因510例（生后≤72 h开始应用；早期应用组），晚期应用咖啡因130例（生后>72 h开始应用；晚期应用组）。比较两组早产儿的临床资料。

结果: 早期应用组和晚期应用组在出生体重、Apgar评分、性别、胎龄、入院年龄等方面的比较差异无统计学意义（P > 0.05）。早期应用组咖啡因应用起始日龄和撤除日龄小于晚期应用组（P < 0.05）；早期应用组咖啡因应用时间短于晚期应用组（P < 0.05）。两组之间入院时呼吸支持情况的比较差异无统计学意义（P > 0.05）。早期应用组呼吸暂停发生率低于晚期应用组（P < 0.05）；早期应用组用氧时间和住院时间短于晚期应用组（P < 0.05）。早期应用组支气管肺发育不良发生率和家庭氧疗率显著低于晚期应用组（P < 0.05）。两组出院时新生儿颅内出血、脑室周围白质软化、坏死性小肠结肠炎、早产儿视网膜病变、动脉导管未闭的发生率和纠正胎龄40周时新生儿神经行为评分的比较差异均无统计学意义（P > 0.05）。两组的病死率比较差异亦无统计学意义（P > 0.05）。

结论: 早产儿（胎龄≤31周）早期应用咖啡因可显著缩短咖啡因应用时间、用氧时间和住院时间，且无明显不良反应。

PubMed Disclaimer

References

    1. Donda K, Vijayakanthi N, Dapaah-Siakwan F, et al. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States. Pediatr Pulmonol. 2019;54(4):405–414. doi: 10.1002/ppul.24241. - DOI - PubMed
    1. Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia:a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–177. doi: 10.1016/j.rmed.2017.10.014. - DOI - PMC - PubMed
    1. Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology. 2017;111(2):107–125. doi: 10.1159/000448985. - DOI - PubMed
    1. Wielenga JM, van den Hoogen A, van Zanten Henriette A, et al. Protocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infants. http://cn.bing.com/academic/profile?id=9e0b66db3a285ca0a39cc5acd667916e&.... Cochrane Database Syst Rev. 2016;3:CD011106. - PMC - PubMed
    1. Steer P, Flenady V, Shearman A, et al. High dose caffeine citrate for extubation of preterm infants:a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F499–F503. doi: 10.1136/adc.2002.023432. - DOI - PMC - PubMed

Publication types